Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 5
2005 4
2006 4
2007 5
2009 1
2010 6
2011 3
2012 4
2013 4
2014 4
2015 3
2016 5
2018 7
2020 3
2021 5
2022 7
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Results by year

Filters applied: . Clear all
Page 1
Public support for and concerns regarding pediatric dose optimization for seizures in emergency medical services: An exception from informed consent (EFIC) trial.
Ward CE, Adelgais KM, Holsti M, Jacobsen KK, Simon HK, Morris CR, Gonzalez VM, Lerner G, Ghaffari K, VanBuren JM, Lerner EB, Shah MI; Pediatric Emergency Care Applied Research Network (PECARN) PediDOSE Study Group. Ward CE, et al. Among authors: gonzalez vm. Acad Emerg Med. 2024 Mar 7. doi: 10.1111/acem.14884. Online ahead of print. Acad Emerg Med. 2024. PMID: 38450918
Safety and Efficacy of ApTOLL in Patients With Ischemic Stroke Undergoing Endovascular Treatment: A Phase 1/2 Randomized Clinical Trial.
Hernández-Jiménez M, Abad-Santos F, Cotgreave I, Gallego J, Jilma B, Flores A, Jovin TG, Vivancos J, Hernández-Pérez M, Molina CA, Montaner J, Casariego J, Dalsgaard M, Liebeskind DS, Cobo E, Castellanos M, Portela PC, Masjuán J, Moniche F, Tembl JI, Terceño Izaga M, Arenillas JF, Callejas P, Olivot JM, Calviere L, Henon H, Mazighi M, Piñeiro D, Pugliese M, González VM, Moro MA, Garcia-Tornel A, Lizasoain I, Ribo M. Hernández-Jiménez M, et al. Among authors: gonzalez vm. JAMA Neurol. 2023 Aug 1;80(8):779-788. doi: 10.1001/jamaneurol.2023.1660. JAMA Neurol. 2023. PMID: 37338893 Clinical Trial.
An Aptamer against MNK1 for Non-Small Cell Lung Cancer Treatment.
Carrión-Marchante R, Pinto-Díez C, Klett-Mingo JI, Palacios E, Barragán-Usero M, Pérez-Morgado MI, Pascual-Mellado M, Alcalá S, Ruiz-Cañas L, Sainz B Jr, González VM, Martín ME. Carrión-Marchante R, et al. Among authors: gonzalez vm. Pharmaceutics. 2023 Apr 18;15(4):1273. doi: 10.3390/pharmaceutics15041273. Pharmaceutics. 2023. PMID: 37111758 Free PMC article.
Potential Therapeutic Use of Aptamers against HAT1 in Lung Cancer.
Klett-Mingo JI, Pinto-Díez C, Cambronero-Plaza J, Carrión-Marchante R, Barragán-Usero M, Pérez-Morgado MI, Rodríguez-Martín E, Toledo-Lobo MV, González VM, Martín ME. Klett-Mingo JI, et al. Among authors: gonzalez vm. Cancers (Basel). 2022 Dec 30;15(1):227. doi: 10.3390/cancers15010227. Cancers (Basel). 2022. PMID: 36612223 Free PMC article.
Enzyme-Linked Oligonucleotide Assay (ELONA).
Moreno M, García-Sacristán A, Martín ME, González VM. Moreno M, et al. Among authors: gonzalez vm. Methods Mol Biol. 2023;2570:235-242. doi: 10.1007/978-1-0716-2695-5_18. Methods Mol Biol. 2023. PMID: 36156787
First-in-human phase I clinical trial of a TLR4-binding DNA aptamer, ApTOLL: Safety and pharmacokinetics in healthy volunteers.
Hernández-Jiménez M, Martín-Vílchez S, Ochoa D, Mejía-Abril G, Román M, Camargo-Mamani P, Luquero-Bueno S, Jilma B, Moro MA, Fernández G, Piñeiro D, Ribó M, González VM, Lizasoain I, Abad-Santos F. Hernández-Jiménez M, et al. Among authors: gonzalez vm. Mol Ther Nucleic Acids. 2022 Mar 9;28:124-135. doi: 10.1016/j.omtn.2022.03.005. eCollection 2022 Jun 14. Mol Ther Nucleic Acids. 2022. PMID: 35402075 Free PMC article.
68 results